Rate-controlled delivery systems in drug and hormone research.
D000818:Animals; D000959:Antihypertensive Agents / Q000009:adverse effects; D002940:Circadian Rhythm; D004343:Drug Implants; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D004702:Endocrine Glands / Q000502:physiology; D004777:Environment; D005260:Female; D005333:Fetus / Q000502:physiology; D006728:Hormones / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D006801:Humans; D007263:Infusions, Parenteral; D007267:Injections; D007269:Injections, Intra-Arterial; D007700:Kinetics; D008954:Models, Biological; D010477:Perfusion; D011247:Pregnancy; D011433:Propranolol / Q000008:administration & dosage / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects; D013312:Stress, Physiological / Q000503:physiopathology; D019966:Substance-Related Disorders
D000959:Antihypertensive Agents; D004343:Drug Implants; D006728:Hormones; D011955:Receptors, Drug; D011433:Propranolol